A citation-based method for searching scientific literature

Rui Li, Ayman Rezk, Yusei Miyazaki, Ellen Hilgenberg, Hanane Touil, Ping Shen, Craig S Moore, Laure Michel, Faisal Althekair, Sathy Rajasekharan, Jennifer L Gommerman, Alexandre Prat, Simon Fillatreau, Amit Bar-Or. Sci Transl Med 2015
Times Cited: 254







List of co-cited articles
1413 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Stephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, Timothy Vollmer, Jack Antel, Robert J Fox, Amit Bar-Or, Michael Panzara, Neena Sarkar, Sunil Agarwal,[...]. N Engl J Med 2008
40

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Giancarlo Comi, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer, Fred Lublin, Xavier Montalban, Kottil W Rammohan, Krzysztof Selmaj,[...]. N Engl J Med 2017
885
38

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.
Ivan Jelcic, Faiez Al Nimer, Jian Wang, Verena Lentsch, Raquel Planas, Ilijas Jelcic, Aleksandar Madjovski, Sabrina Ruhrmann, Wolfgang Faigle, Katrin Frauenknecht,[...]. Cell 2018
232
34

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
Amit Bar-Or, Lama Fawaz, Boli Fan, Peter J Darlington, Aja Rieger, Christine Ghorayeb, Peter A Calabresi, Emmanuelle Waubant, Stephen L Hauser, Jiameng Zhang,[...]. Ann Neurol 2010
336
34

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Giancarlo Comi, Jérôme de Seze, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer,[...]. N Engl J Med 2017
916
34

B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Tom A Barr, Ping Shen, Sheila Brown, Vicky Lampropoulou, Toralf Roch, Sarah Lawrie, Boli Fan, Richard A O'Connor, Stephen M Anderton, Amit Bar-Or,[...]. J Exp Med 2012
411
32

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.
Martin Duddy, Masaaki Niino, Femina Adatia, Sherry Hebert, Mark Freedman, Harry Atkins, Ho Jin Kim, Amit Bar-Or. J Immunol 2007
457
31

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.
Roberta Magliozzi, Owain Howell, Abhilash Vora, Barbara Serafini, Richard Nicholas, Maria Puopolo, Richard Reynolds, Francesca Aloisi. Brain 2007
919
29

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.
Barbara Serafini, Barbara Rosicarelli, Roberta Magliozzi, Egidio Stigliano, Francesca Aloisi. Brain Pathol 2004
816
25

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
Amit Bar-Or, Peter A J Calabresi, Douglas Arnold, Clyde Markowitz, Stuart Shafer, Lloyd H Kasper, Emmanuelle Waubant, Suzanne Gazda, Robert J Fox, Michael Panzara,[...]. Ann Neurol 2008
383
22

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Kathleen Hawker, Paul O'Connor, Mark S Freedman, Peter A Calabresi, Jack Antel, Jack Simon, Stephen Hauser, Emmanuelle Waubant, Timothy Vollmer, Hillel Panitch,[...]. Ann Neurol 2009
608
22

Reassessing B cell contributions in multiple sclerosis.
Rui Li, Kristina R Patterson, Amit Bar-Or. Nat Immunol 2018
189
21

MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
Nicolas Molnarfi, Ulf Schulze-Topphoff, Martin S Weber, Juan C Patarroyo, Thomas Prod'homme, Michel Varrin-Doyer, Aparna Shetty, Christopher Linington, Anthony J Slavin, Juan Hidalgo,[...]. J Exp Med 2013
264
20

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
C Lucchinetti, W Brück, J Parisi, B Scheithauer, M Rodriguez, H Lassmann. Ann Neurol 2000
19

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.
Owain W Howell, Cheryl A Reeves, Richard Nicholas, Daniele Carassiti, Bishan Radotra, Steve M Gentleman, Barbara Serafini, Francesca Aloisi, Federico Roncaroli, Roberta Magliozzi,[...]. Brain 2011
517
19

The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
Joana Machado-Santos, Etsuji Saji, Anna R Tröscher, Manuela Paunovic, Roland Liblau, Galina Gabriely, Christian G Bien, Jan Bauer, Hans Lassmann. Brain 2018
240
18

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.
Roberta Magliozzi, Owain W Howell, Cheryl Reeves, Federico Roncaroli, Richard Nicholas, Barbara Serafini, Francesca Aloisi, Richard Reynolds. Ann Neurol 2010
459
17

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Ping Shen, Toralf Roch, Vicky Lampropoulou, Richard A O'Connor, Ulrik Stervbo, Ellen Hilgenberg, Stefanie Ries, Van Duc Dang, Yarúa Jaimes, Capucine Daridon,[...]. Nature 2014
689
17

B cells regulate autoimmunity by provision of IL-10.
Simon Fillatreau, Claire H Sweenie, Mandy J McGeachy, David Gray, Stephen M Anderton. Nat Immunol 2002
17

Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, Giancarlo Comi, Jorge Correale, Patricia K Coyle, Anne H Cross, Jerome de Seze, David Leppert, Xavier Montalban,[...]. N Engl J Med 2020
183
17

Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation.
Masanori Matsumoto, Akemi Baba, Takafumi Yokota, Hiroyoshi Nishikawa, Yasuyuki Ohkawa, Hisako Kayama, Axel Kallies, Stephen L Nutt, Shimon Sakaguchi, Kiyoshi Takeda,[...]. Immunity 2014
345
16

Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.
Birgit Obermeier, Reinhard Mentele, Joachim Malotka, Josef Kellermann, Tania Kümpfel, Hartmut Wekerle, Friedrich Lottspeich, Reinhard Hohlfeld, Klaus Dornmair. Nat Med 2008
195
15

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients.
Anne H Cross, Jennifer L Stark, Joanne Lauber, Michael J Ramsbottom, Jeri-Anne Lyons. J Neuroimmunol 2006
323
15

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
Ludwig Kappos, David Li, Peter A Calabresi, Paul O'Connor, Amit Bar-Or, Frederik Barkhof, Ming Yin, David Leppert, Robert Glanzman, Jeroen Tinbergen,[...]. Lancet 2011
485
15

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Amit Bar-Or, Richard A Grove, Daren J Austin, Jerry M Tolson, Susan A VanMeter, Eric W Lewis, Frederick J Derosier, Monica C Lopez, Sarah T Kavanagh, Aaron E Miller,[...]. Neurology 2018
102
15

Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.
Arumugam Palanichamy, Sarah Jahn, Dorothee Nickles, Mia Derstine, Aya Abounasr, Stephen L Hauser, Sergio E Baranzini, David Leppert, H-Christian von Büdingen. J Immunol 2014
166
14

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas, Massimo Filippi, Mark S Freedman,[...]. Lancet Neurol 2018
14

B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
Joel N H Stern, Gur Yaari, Jason A Vander Heiden, George Church, William F Donahue, Rogier Q Hintzen, Anita J Huttner, Jon D Laman, Rashed M Nagra, Alyssa Nylander,[...]. Sci Transl Med 2014
296
14

Inflammatory cortical demyelination in early multiple sclerosis.
Claudia F Lucchinetti, Bogdan F G Popescu, Reem F Bunyan, Natalia M Moll, Shanu F Roemer, Hans Lassmann, Wolfgang Brück, Joseph E Parisi, Bernd W Scheithauer, Caterina Giannini,[...]. N Engl J Med 2011
710
14

Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
Marina R von Essen, Cecilie Ammitzbøll, Rikke H Hansen, Eva R S Petersen, Oskar McWilliam, Hanne V Marquart, Peter Damm, Finn Sellebjerg. Brain 2019
51
25

Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.
Laura Piccio, Robert T Naismith, Kathryn Trinkaus, Robyn S Klein, Becky J Parks, Jeri A Lyons, Anne H Cross. Arch Neurol 2010
174
13

Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.
Roberta Magliozzi, Owain W Howell, Richard Nicholas, Carolina Cruciani, Marco Castellaro, Chiara Romualdi, Stefania Rossi, Marco Pitteri, Maria Donata Benedetti, Alberto Gajofatto,[...]. Ann Neurol 2018
146
13

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.
Paul A Blair, Lina Yassin Noreña, Fabian Flores-Borja, David J Rawlings, David A Isenberg, Michael R Ehrenstein, Claudia Mauri. Immunity 2010
13

Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.
Simone M Brändle, Birgit Obermeier, Makbule Senel, Jessica Bruder, Reinhard Mentele, Mohsen Khademi, Tomas Olsson, Hayrettin Tumani, Wolfgang Kristoferitsch, Friedrich Lottspeich,[...]. Proc Natl Acad Sci U S A 2016
101
13

Immunopathology of multiple sclerosis.
Calliope A Dendrou, Lars Fugger, Manuel A Friese. Nat Rev Immunol 2015
12


Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties.
Christian Klein, Alfred Lammens, Wolfgang Schäfer, Guy Georges, Manfred Schwaiger, Ekkehard Mössner, Karl-Peter Hopfner, Pablo Umaña, Gerhard Niederfellner. MAbs 2013
200
12

Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
Robert P Lisak, Joyce A Benjamins, Liljana Nedelkoska, Jennifer L Barger, Samia Ragheb, Boli Fan, Nadia Ouamara, Trina A Johnson, Sathyanath Rajasekharan, Amit Bar-Or. J Neuroimmunol 2012
116
12

B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro.
Robert P Lisak, Liljana Nedelkoska, Joyce A Benjamins, Dana Schalk, Beverly Bealmear, Hanane Touil, Rui Li, Gillian Muirhead, Amit Bar-Or. J Neuroimmunol 2017
63
19

Identification of autoantibodies associated with myelin damage in multiple sclerosis.
C P Genain, B Cannella, S L Hauser, C S Raine. Nat Med 1999
683
12

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
Martin S Weber, Thomas Prod'homme, Juan C Patarroyo, Nicolas Molnarfi, Tara Karnezis, Klaus Lehmann-Horn, Dimitry M Danilenko, Jeffrey Eastham-Anderson, Anthony J Slavin, Christopher Linington,[...]. Ann Neurol 2010
216
12

Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
Ludwig Kappos, Hans-Peter Hartung, Mark S Freedman, Alexey Boyko, Ernst Wilhelm Radü, Daniel D Mikol, Marc Lamarine, Yann Hyvert, Ulrich Freudensprung, Thomas Plitz,[...]. Lancet Neurol 2014
201
12

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.
Yohei Iwata, Takashi Matsushita, Mayuka Horikawa, David J Dilillo, Koichi Yanaba, Guglielmo M Venturi, Paul M Szabolcs, Steven H Bernstein, Cynthia M Magro, Armistead D Williams,[...]. Blood 2011
794
12

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
Xavier Montalban, Douglas L Arnold, Martin S Weber, Ivan Staikov, Karolina Piasecka-Stryczynska, Jonathan Willmer, Emily C Martin, Fernando Dangond, Sana Syed, Jerry S Wolinsky. N Engl J Med 2019
145
12

Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.
David Baker, Monica Marta, Gareth Pryce, Gavin Giovannoni, Klaus Schmierer. EBioMedicine 2017
161
11

Multiple Sclerosis: Mechanisms and Immunotherapy.
Clare Baecher-Allan, Belinda J Kaskow, Howard L Weiner. Neuron 2018
412
11

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Sung R Choi, Owain W Howell, Daniele Carassiti, Roberta Magliozzi, Djordje Gveric, Paolo A Muraro, Richard Nicholas, Federico Roncaroli, Richard Reynolds. Brain 2012
229
11

Multiple Sclerosis.
Daniel S Reich, Claudia F Lucchinetti, Peter A Calabresi. N Engl J Med 2018
11

The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Josa M Frischer, Stephan Bramow, Assunta Dal-Bianco, Claudia F Lucchinetti, Helmut Rauschka, Manfred Schmidbauer, Henning Laursen, Per Soelberg Sorensen, Hans Lassmann. Brain 2009
937
10

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
Jonatan Salzer, Rasmus Svenningsson, Peter Alping, Lenka Novakova, Anna Björck, Katharina Fink, Protik Islam-Jakobsson, Clas Malmeström, Markus Axelsson, Mattias Vågberg,[...]. Neurology 2016
204
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.